Skip to Content

0665 4160 (Lithium Carbonate 300 mg)

Pill with imprint 0665 4160 is White, and has been identified as Lithium Carbonate 300 mg. It is supplied by Watson Pharmaceuticals.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; mania; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 0665 4160

Lithium Carbonate

Imprint:
0665 4160
Strength:
300 mg
Color:
White
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
National Drug Code (NDC):
00364-0855

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide